Blood test could help doctors choose best cancer treatment for seniors
NCT ID NCT02807129
First seen Jan 22, 2026 · Last updated May 16, 2026 · Updated 23 times
Summary
This study looked at whether a blood test measuring elastin fragments can help doctors assess frailty in people 65 and older with cancer. Frailty affects how well patients tolerate treatment, but current methods are subjective and slow. The goal was to find a faster, more objective way to guide treatment decisions for this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Damien JOLLY
Reims, 51092, France
Conditions
Explore the condition pages connected to this study.